Detecting supraventricular tachycardia with smartwatches facilitates the decision for catheter ablation: A case series.
Shang-Ju WuCheng-Hung LiJiunn-Cherng LinChi-Jen WengWei-Wen LinYu Cheng HsiehPublished in: Pacing and clinical electrophysiology : PACE (2021)
Smartwatch allows easy detection of arrhythmia. Such an approach is widely used for detecting atrial fibrillation. However, there has been no consensus on the diagnostic power of smartwatch-detected supraventricular tachycardia (SVT). We reported three patients of SVT presenting with infrequent palpitations. Their SVTs were not documented with single-lead or standard ECG in hospital before, but only recorded by the single-lead ECG on smartwatches. Electrophysiological studies confirmed the mechanisms of these SVTs and led to successful catheter ablations. In conclusion, in patients with recurrent symptomatic tachycardia and a smartwatch-detected SVT, an electrophysiological study is indicated rather than to wait for a standard ECG for clinical decision. This approach might prevent the delay for successful treatment.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- heart rate variability
- heart rate
- ejection fraction
- end stage renal disease
- oral anticoagulants
- newly diagnosed
- healthcare
- direct oral anticoagulants
- heart failure
- decision making
- chronic kidney disease
- prognostic factors
- blood pressure
- percutaneous coronary intervention
- patient reported outcomes
- emergency department
- clinical practice
- ultrasound guided
- acute care
- case report
- case control
- electronic health record